文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

AMPK激活通过抑制铁死亡减轻脂多糖诱导的脓毒症相关急性肾损伤

[AMP-activated protein kinase activation alleviates lipopolysaccharide-induced sepsis-associated acute kidney injury by inhibiting ferroptosis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论小鼠实验中,AMPK激活剂AICAR(500 mg/kg腹腔注射)可减轻LPS诱导的脓毒症相关急性肾损伤,机制可能涉及Nrf2/HO-1通路抑制铁死亡。

该研究将30只SPF雄性C57BL/6小鼠随机分为对照组、LPS组和LPS+AICAR组,每组10只。LPS+AICAR组在造模前30分钟腹腔注射AICAR 500 mg/kg,LPS组和对照组腹腔注射等量生理盐水;SA-AKI模型通过腹腔注射LPS 10 mg/kg诱导。结果显示,与LPS组相比,LPS+AICAR组血清炎症因子(IL-1β、IL-6、TNF-α)、肾功能指标(SCr、BUN)及肾组织Fe2+、MDA水平显著降低,GSH水平及AMPK、SLC7A11、GPX4、Nrf2、HO-1表达显著升高(均P<0.05),肾小管结构损伤和线粒体铁死亡特征明显减轻。结论认为AMPK可能通过Nrf2/HO-1信号通路抑制铁死亡,对LPS诱导的小鼠SA-AKI发挥保护作用。

要点

  • 小鼠SA-AKI模型中,LPS组较对照组血清SCr(57.63±6.37 vs 31.75±5.08 μmol/L)、BUN(36.35±5.47 vs 23.93±4.44 mmol/L)显著升高,AICAR干预后显著降低(均P<0.05)。
  • LPS+AICAR组较LPS组血清IL-1β(68.93±9.37 vs 91.25±10.55 ng/L)、IL-6(80.03±7.86 vs 93.10±6.16 ng/L)、TNF-α(484.77±51.00 vs 558.59±48.54 ng/L)显著降低(均P<0.05)。
  • LPS+AICAR组较LPS组肾组织Fe2+(4.02±0.74 vs 6.84±1.41 μmol/g)、MDA(1.44±0.62 vs 2.62±0.62 μmol/g)显著降低,GSH(4.35±0.50 vs 3.49±0.94 μmol/kg)升高(均P<0.05)。
  • AICAR干预后肾组织AMPK、SLC7A11、GPX4、Nrf2、HO-1的mRNA和蛋白表达较LPS组显著上调(均P<0.05),ACSL4表达显著下调。
  • 作者认为AMPK可能通过Nrf2/HO-1信号通路抑制铁死亡,从而减轻LPS诱导的小鼠SA-AKI。

适用人群与场景

  • SPF雄性C57BL/6小鼠,用于LPS诱导的脓毒症相关急性肾损伤(SA-AKI)模型研究。

处置流程与药物剂量

  • LPS+AICAR组在造模前30分钟腹腔注射AICAR 500 mg/kg进行干预;对照组和LPS组腹腔注射等量生理盐水。
  • SA-AKI模型通过腹腔注射LPS 10 mg/kg诱导;对照组腹腔注射等量生理盐水。

研究设计与关键结果

  • 研究类型为动物实验,30只SPF雄性C57BL/6小鼠随机分为对照组、LPS组和LPS+AICAR组,每组10只。
  • 与对照组相比,LPS组出现肾小管结构紊乱、空泡变性、坏死脱落、间质水肿和炎性细胞浸润,线粒体呈现典型铁死亡特征,血清IL-1β、IL-6、TNF-α、SCr、BUN显著升高,肾组织Fe2+、MDA及ACSL4 mRNA和蛋白表达升高,GSH、AMPK蛋白、SLC7A11、GPX4、Nrf2、HO-1的mRNA和蛋白表达显著降低(均P<0.05)。
  • 与LPS组相比,LPS+AICAR组肾小管结构损伤和空泡变性显著减轻,间质水肿和炎性浸润减少,线粒体铁死亡相关超微结构改变明显改善。
  • LPS+AICAR组较LPS组血清IL-1β(68.93±9.37 vs 91.25±10.55 ng/L)、IL-6(80.03±7.86 vs 93.10±6.16 ng/L)、TNF-α(484.77±51.00 vs 558.59±48.54 ng/L)、SCr(31.75±5.08 vs 57.63±6.37 μmol/L)、BUN(23.93±4.44 vs 36.35±5.47 mmol/L)显著降低(均P<0.05)。
  • LPS+AICAR组较LPS组肾组织Fe2+(4.02±0.74 vs 6.84±1.41 μmol/g)、MDA(1.44±0.62 vs 2.62±0.62 μmol/g)显著降低,ACSL4 mRNA(1.98±0.50 vs 3.67±0.80)和ACSL4/GAPDH(0.49±0.08 vs 0.94±0.12)显著下调(均P<0.05)。
  • LPS+AICAR组较LPS组肾组织GSH升高(4.35±0.50 vs 3.49±0.94 μmol/kg),AMPK mRNA(2.68±0.27 vs 1.22±0.24)、SLC7A11 mRNA(0.04±0.01 vs 0.01±0.00)、GPX4 mRNA(5.15±1.21 vs 3.40±0.45)、Nrf2 mRNA(0.57±0.29 vs 0.22±0.23)、HO-1 mRNA(0.12±0.03 vs 0.02±0.01)及p-AMPK/AMPK(1.19±0.14 vs 0.50±0.15)、SLC7A11/GAPDH(0.55±0.07 vs 0.34±0.10)、GPX4/GAPDH(0.56±0.11 vs 0.18±0.08)、Nrf2/GAPDH(0.89±0.20 vs 0.36±0.08)、HO-1/GAPDH(0.75±0.07 vs 0.5

证据类型、等级与局限

  • 证据类型:动物实验(小鼠在体实验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该研究为小鼠实验,作者认为AMPK可能通过Nrf2/HO-1信号通路抑制铁死亡,对LPS诱导的SA-AKI发挥保护作用;原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the regulatory role of AMP-activated protein kinase (AMPK) activation in ferroptosis during lipopolysaccharide (LPS)-induced sepsis-associated acute kidney injury (SA-AKI) and its molecular mechanisms.

METHODS: Thirty SPF male C57BL/6 mice were randomly assigned to the control group, LPS group, and LPS+AMPK activator (AICAR) group using a random number table method, with 10 mice per group. Mice in the LPS+AICAR group received an intraperitoneal injection of AICAR at a dose of 500 mg/kg for intervention 30 minutes prior to model establishment, while those in the control group and LPS group were intraperitoneally injected with an equal volume of normal saline. The SA-AKI model was induced via intraperitoneal injection of LPS at 10 mg/kg, and the control group was intraperitoneally administered an equal volume of normal saline. Enzyme-linked immunosorbent assay (ELISA) was performed to measure the serum concentrations of inflammatory factors [including interleukins (IL-1β, IL-6), and tumor necrosis factor-α (TNF-α)]. Serum renal function indicators [including serum creatinine (SCr) and blood urea nitrogen (BUN)], as well as the levels of key ferroptosis-related factors [including Fe2+, malondialdehyde (MDA), and glutathione (GSH)] in renal tissues were measured using biochemical assays. Hematoxylin-eosin (HE) staining was conducted to observe histopathological changes in renal tissues under a light microscope, and transmission electron microscopy was used to examine the ultrastructural alterations of mitochondria in renal tissues. Quantitative real-time polymerase chain reaction (RT-qPCR) and Western blotting were employed to determine the mRNA and protein expression levels of AMPK, key ferroptosis-related enzymes [long-chain acyl-CoA synthetase 4 (ACSL4), solute carrier family 7 member 11 (SLC7A11), and glutathione peroxidase 4 (GPX4)], as well as the nuclear factor E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway-related molecules in renal tissues.

RESULTS: Compared with the control group, mice in the LPS group exhibited renal tubular structural disorder, with vacuolar degeneration, necrosis, and shedding of epithelial cells, interstitial edema, and inflammatory cell infiltration. Mitochondria in renal tissues showed typical ferroptosis characteristics. Moreover, the levels of serum IL-1β, IL-6, TNF-α, SCr, and BUN were significantly elevated. In renal tissues, the levels of Fe2+ and MDA, along with the mRNA and protein expression of ACSL4, were increased, whereas the GSH level, protein expression of AMPK, and mRNA and protein expression of SLC7A11, GPX4, Nrf2, and HO-1 were markedly decreased (all P<0.05). In contrast to the LPS group, mice in the LPS+AICAR group displayed significant alleviation of renal tubular structural damage and vacuolar degeneration, as well as reduced interstitial edema and inflammatory infiltration. The ferroptosis-related ultrastructural changes in renal mitochondria were also notably ameliorated. The serum concentrations of IL-1β, IL-6, TNF-α, SCr, and BUN were significantly lower in the LPS+AICAR group than in the LPS group [IL-1β (ng/L): 68.93±9.37 vs. 91.25±10.55, IL-6 (ng/L): 80.03±7.86 vs. 93.10±6.16, TNF-α (ng/L): 484.77±51.00 vs. 558.59±48.54, SCr (μmol/L): 31.75±5.08 vs. 57.63±6.37, BUN (mmol/L): 23.93±4.44 vs. 36.35±5.47, all P<0.05]. Additionally, the levels of Fe2+ and MDA in renal tissues were significantly reduced in the LPS+AICAR group compared with the LPS group [Fe2+ (μmol/g): 4.02±0.74 vs. 6.84±1.41, MDA (μmol/g): 1.44±0.62 vs. 2.62±0.62, both P<0.05], accompanied by downregulated mRNA and protein expression of ACSL4 (ACSL4 mRNA: 1.98±0.50 vs. 3.67±0.80, ACSL4/GAPDH: 0.49±0.08 vs. 0.94±0.12, both P<0.05). Furthermore, the renal GSH level was higher in the LPS+AICAR group than in the LPS group (μmol/kg: 4.35±0.50 vs. 3.49±0.94), along with significantly upregulated mRNA and protein expression of AMPK, SLC7A11, GPX4, Nrf2, and HO-1 [mRNA expression: AMPK mRNA (2-ΔΔCt): 2.68±0.27 vs. 1.22±0.24, SLC7A11 mRNA (2-ΔΔCt): 0.04±0.01 vs. 0.01±0.00, GPX4 mRNA (2-ΔΔCt): 5.15±1.21 vs. 3.40±0.45, Nrf2 mRNA (2-ΔΔCt): 0.57±0.29 vs. 0.22±0.23, HO-1 mRNA (2-ΔΔCt): 0.12±0.03 vs. 0.02±0.01; protein expression: p-AMPK/AMPK ratio: 1.19±0.14 vs. 0.50±0.15, SLC7A11/GAPDH: 0.55±0.07 vs. 0.34±0.10, GPX4/GAPDH: 0.56±0.11 vs. 0.18±0.08, Nrf2/GAPDH: 0.89±0.20 vs. 0.36±0.08, HO-1/GAPDH: 0.75±0.07 vs. 0.54±0.06, all P<0.05].

CONCLUSIONS: AMPK may exert protective effects against LPS-induced SA-AKI in mice by inhibiting ferroptosis through the Nrf2/HO-1 signaling pathway.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wang M, Kang Y, Zhang B, et al. [AMP-activated protein kinase activation alleviates lipopolysaccharide-induced sepsis-associated acute kidney injury by inhibiting ferroptosis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 41958127. doi:10.3760/cma.j.cn121430-20250303-00123

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。